缺血性与出血性脑卒中严重程度及结局的二十年变化
该研究基于日本卒中数据库,纳入2000年1月至2019年12月发病7天内登记的急性缺血性与出血性卒中患者183 080例,分析初始神经功能严重程度与出院时改良Rankin量表评分的性别别长期变化。多因素分析显示三种卒中类型入院时评分均下降、发病年龄中位数上升;缺血性卒中年龄校正后良好结局增加,但进一步校正再灌注治疗后趋于停滞,男性甚至下降;出血性卒中结局未明显改善。
要点
- 缺血性卒中良好结局在年龄校正后随时间增加,但校正再灌注治疗后趋于停滞,男性甚至下降
- 三种卒中类型初始神经功能严重程度评分在20年间均下降,发病年龄中位数均上升
- 脑出血良好结局在男女两性均减少,蛛网膜下腔出血良好结局比例不变
核心结论
- 过去20年缺血性卒中患者功能结局在两性中均有改善,作者推测部分归因于急性再灌注治疗的发展;同期出血性卒中患者结局未明显改善。
研究设计与样本
- 日本全国性、医院为基础、多中心、前瞻性登记队列研究,使用日本卒中数据库,纳入2000年1月至2019年12月发病7天内登记的急性缺血性与出血性卒中患者共183 080例,出院时评估改良Rankin量表评分。
主要发现
- 183 080例中,缺血性卒中135 266例(女性53 800例,占39.8%;年龄中位数74岁,IQR 66-82岁),脑出血36 014例(女性15 365例,占42.7%;年龄中位数70岁,IQR 59-79岁),蛛网膜下腔出血11 800例(女性7924例,占67.2%;年龄中位数64岁,IQR 53-75岁)。
- 缺血性卒中年龄校正后良好结局随时间增加(女性OR 1.020,95%CI 1.015-1.024;男性OR 1.015,95%CI 1.011-1.018),进一步多因素校正包括再灌注治疗后趋于停滞或男性下降(女性OR 0.997,95%CI 0.991-1.003;男性OR 0.990,95%CI 0.985-0.994)。
- 缺血性卒中不良结局和院内死亡在两性中均下降;脑出血良好结局在两性中均减少,不良结局和死亡仅在女性中下降;蛛网膜下腔出血良好结局比例不变,不良结局和死亡在两性中均下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Whether recent changes in demographic characteristics and therapeutic technologies have altered stroke outcomes remains unknown. OBJECTIVE: To determine secular changes in initial neurological severity and short-term functional outcomes of patients with acute stroke by sex using a large population. DESIGN, SETTING, AND PARTICIPANTS: This nationwide, hospital-based, multicenter, prospective registry cohort study used the Japan Stroke Data Bank and included patients who developed acute stroke from January 2000 through December 2019. Patients with stroke, including ischemic and hemorrhagic strokes, who registered within 7 days after symptom onset were studied. Modified Rankin Scale scores were assessed at hospital discharge for all patients. EXPOSURE: Time. MAIN OUTCOMES AND MEASURES: Initial severity was assessed by the National Institutes of Health Stroke Scale for ischemic stroke and intracerebral hemorrhage and by the World Federation of Neurological Surgeons grading for subarachnoid hemorrhage. Outcomes were judged as favorable if the modified Rankin Scale score was 0 to 2 and unfavorable if 5 to 6. RESULTS: Of 183 080 patients, 135 266 (53 800 women [39.8%]; median [IQR] age, 74 [66-82] years) developed ischemic stroke, 36 014 (15 365 women [42.7%]; median [IQR] age, 70 [59-79] years) developed intracerebral hemorrhage, and 11 800 (7924 women [67.2%]; median [IQR] age, 64 [53-75] years) developed subarachnoid hemorrhage. In all 3 stroke types, median ages at onset increased, and the National Institutes of Health Stroke Scale and World Federation of Neurological Surgeons scores decreased throughout the 20-year period on multivariable analysis. In ischemic stroke, the proportion of favorable outcomes showed an increase over time after age adjustment (odds ratio [OR], 1.020; 95% CI, 1.015-1.024 for women vs OR, 1.015; 95% CI, 1.011-1.018 for men) but then stagnated, or even decreased in men, on multivariate adjustment including reperfusion therapy (OR, 0.997; 95% CI, 0.991-1.003 for women vs OR, 0.990; 95% CI, 0.985-0.994 for men). Unfavorable outcomes and in-hospital deaths decreased in both sexes. In intracerebral hemorrhage, favorable outcomes decreased in both sexes, and unfavorable outcomes and deaths decreased only in women. In subarachnoid hemorrhage, the proportion of favorable outcomes was unchanged, and that of unfavorable outcomes and deaths decreased in both sexes. CONCLUSIONS AND RELEVANCE: In this study, functional outcomes improved in patients with ischemic stroke during the past 20 years in both sexes presumably partly owing to the development of acute reperfusion therapy. The outcomes of patients with hemorrhagic stroke did not clearly improve in the same period.
引用
- Toyoda K, Yoshimura S, Nakai M, et al. Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol. 2022. PMID: 34870689. doi:10.1001/jamaneurol.2021.4346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。